UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
Sanofi provides update on MOBILIZE phase 3 study of riliprubart in chronic inflammatory demyelinating polyneuropathy
Sanofi has announced the discontinuation of its Phase 3 MOBILIZE study evaluating…
FDA approves Lilly’s EBGLYSS® for one maintenance dose every eight weeks in patients with moderate-to-severe atopic dermatitis
The U.S. FDA has approved a new maintenance dosing regimen for Eli…
Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors
Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…
Antag Therapeutics appoints obesity treatment pioneer Philip Just Larsen as Chief Executive Officer
Antag Therapeutics has appointed obesity treatment expert Philip Just Larsen as Chief…
London Biotechnology Show 2026
London Biotechnology Show 2026 will unite global biotech leaders, pharmaceutical companies, investors,…
Boston Scientific Announces Strategic Investment in MiRus LLC
Boston Scientific announced a $1.5 billion investment in MiRus LLC to support…
ImmunityBio Signs Exclusive U.S. Agreement with Japan BCG Laboratory to Expand BCG Supply in the United States
ImmunityBio has signed an exclusive U.S. development and supply agreement with Japan…
Dubai Health and DNDi Sign MoU to Combat Neglected Diseases
Dubai Health and the Drugs for Neglected Diseases initiative (DNDi) have signed…
Matt Bonam appointed as Executive Director at the BHF Data Science Centre
Matt Bonam has been appointed Executive Director of the BHF Data Science…
